Annual SG&A
$35.50 M
+$5.48 M+18.24%
31 December 2023
Summary:
Tango Therapeutics annual selling, general & administrative expenses is currently $35.50 million, with the most recent change of +$5.48 million (+18.24%) on 31 December 2023. During the last 3 years, it has risen by +$25.64 million (+259.88%). TNGX annual SG&A is now at all-time high.TNGX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$11.22 M
+$449.00 K+4.17%
30 September 2024
Summary:
Tango Therapeutics quarterly selling, general & administrative expenses is currently $11.22 million, with the most recent change of +$449.00 thousand (+4.17%) on 30 September 2024. Over the past year, it has increased by +$2.01 million (+21.86%). TNGX quarterly SG&A is now at all-time high.TNGX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.68 B
-$123.39 M-7.93%
30 September 2024
Summary:
Tango Therapeutics TTM selling, general & administrative expenses is currently -$1.68 billion, with the most recent change of -$123.39 million (-7.93%) on 30 September 2024. Over the past year, it has dropped by -$1.71 billion (-4997.57%). TNGX TTM SG&A is now -1528.53% below its all-time high of $41.76 million, reached on 30 September 2024.TNGX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TNGX Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.2% | +21.9% | -4997.6% |
| 3 y3 years | +259.9% | +153.2% | -10000.0% |
| 5 y5 years | - | - | - |
TNGX Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +259.9% | at high | +153.2% | -592.7% | at low |
| 5 y | 5 years | at high | +259.9% | at high | +345.7% | -1528.5% | at low |
| alltime | all time | at high | +259.9% | at high | +345.7% | -1528.5% | at low |
Tango Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $11.22 M(+4.2%) | $41.76 M(+5.1%) |
| June 2024 | - | $10.77 M(+1.1%) | $39.75 M(+4.2%) |
| Mar 2024 | - | $10.66 M(+17.1%) | $38.15 M(+7.5%) |
| Dec 2023 | $35.50 M(+18.2%) | $9.11 M(-1.1%) | $35.50 M(+3.6%) |
| Sept 2023 | - | $9.21 M(+0.4%) | $34.28 M(+3.3%) |
| June 2023 | - | $9.17 M(+14.5%) | $33.17 M(+6.2%) |
| Mar 2023 | - | $8.01 M(+1.6%) | $31.23 M(+4.0%) |
| Dec 2022 | $30.02 M | $7.89 M(-2.6%) | $30.02 M(+6.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $8.10 M(+12.0%) | $28.20 M(+14.9%) |
| June 2022 | - | $7.23 M(+6.2%) | $24.54 M(+17.2%) |
| Mar 2022 | - | $6.81 M(+12.2%) | $20.94 M(+19.0%) |
| Dec 2021 | $17.60 M(+78.4%) | $6.07 M(+36.8%) | $17.60 M(+21.0%) |
| Sept 2021 | - | $4.43 M(+22.1%) | $14.55 M(+15.2%) |
| June 2021 | - | $3.63 M(+4.7%) | $12.63 M(+40.3%) |
| Mar 2021 | - | $3.47 M(+15.0%) | $9.00 M(+62.6%) |
| Dec 2020 | $9.87 M | $3.02 M(+19.8%) | $5.53 M(+119.8%) |
| Sept 2020 | - | $2.52 M | $2.52 M |
FAQ
- What is Tango Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Tango Therapeutics?
- What is Tango Therapeutics annual SG&A year-on-year change?
- What is Tango Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Tango Therapeutics?
- What is Tango Therapeutics quarterly SG&A year-on-year change?
- What is Tango Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Tango Therapeutics?
- What is Tango Therapeutics TTM SG&A year-on-year change?
What is Tango Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of TNGX is $35.50 M
What is the all time high annual SG&A for Tango Therapeutics?
Tango Therapeutics all-time high annual selling, general & administrative expenses is $35.50 M
What is Tango Therapeutics annual SG&A year-on-year change?
Over the past year, TNGX annual selling, general & administrative expenses has changed by +$5.48 M (+18.24%)
What is Tango Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of TNGX is $11.22 M
What is the all time high quarterly SG&A for Tango Therapeutics?
Tango Therapeutics all-time high quarterly selling, general & administrative expenses is $11.22 M
What is Tango Therapeutics quarterly SG&A year-on-year change?
Over the past year, TNGX quarterly selling, general & administrative expenses has changed by +$2.01 M (+21.86%)
What is Tango Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of TNGX is -$1.68 B
What is the all time high TTM SG&A for Tango Therapeutics?
Tango Therapeutics all-time high TTM selling, general & administrative expenses is $41.76 M
What is Tango Therapeutics TTM SG&A year-on-year change?
Over the past year, TNGX TTM selling, general & administrative expenses has changed by -$1.71 B (-4997.57%)